Report Summary
Eternity Insights has published a new study on Global Continuous Blood Glucose Monitoring Market focusing on key segments as by Type (Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems, Other), by Application (Hospitals, Clinics, Home Care, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Continuous Blood Glucose Monitoring Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Continuous Blood Glucose Monitoring Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Continuous Blood Glucose Monitoring Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Continuous Blood Glucose Monitoring Market Segmentation:
Continuous Blood Glucose Monitoring Market, By Type
- Self-Monitoring Blood Glucose Systems
- Continuous Glucose Monitoring Systems
- Other
Continuous Blood Glucose Monitoring Market, By Application
- Hospitals
- Clinics
- Home Care
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Continuous Blood Glucose Monitoring market in terms of demand generation. The Continuous Blood Glucose Monitoring market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Continuous Blood Glucose Monitoring market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Continuous Blood Glucose Monitoring Market Taxonomy:
To learn more about this report
Global Continuous Blood Glucose Monitoring Market Competitive Landscape
The global Continuous Blood Glucose Monitoring market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Roche
- Lifescan
- Medtronic
- Bayer AG
- Abbott
- Terumo
- Dexcom
- Echo Therapeutics
- B. Braun Melsungen
- Arkray
- Cellnovo Group
- Nemaura
- Tandem Diabetes Care
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems, Other |
| By Application Outlook |
Hospitals, Clinics, Home Care, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Roche, Lifescan, Medtronic, Bayer AG, Abbott, Terumo, Dexcom, Echo Therapeutics, B. Braun Melsungen, Arkray, Cellnovo Group, Nemaura, Tandem Diabetes Care |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Continuous Blood Glucose Monitoring Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Continuous Blood Glucose Monitoring Market Size Growth Rate by Product
1.4.2 Self-Monitoring Blood Glucose Systems
1.4.3 Continuous Glucose Monitoring Systems
1.5 Market by End User
1.5.1 Global Continuous Blood Glucose Monitoring Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Continuous Blood Glucose Monitoring Market Size
2.1.1 Global Continuous Blood Glucose Monitoring Revenue 2017-2027
2.1.2 Global Continuous Blood Glucose Monitoring Sales 2017-2027
2.2 Continuous Blood Glucose Monitoring Growth Rate by Regions
2.2.1 Global Continuous Blood Glucose Monitoring Sales by Regions
2.2.2 Global Continuous Blood Glucose Monitoring Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Continuous Blood Glucose Monitoring Sales by Manufacturers
3.1.1 Continuous Blood Glucose Monitoring Sales by Manufacturers
3.1.2 Continuous Blood Glucose Monitoring Sales Market Share by Manufacturers
3.1.3 Global Continuous Blood Glucose Monitoring Market Concentration Ratio (CR5 and HHI)
3.2 Continuous Blood Glucose Monitoring Revenue by Manufacturers
3.2.1 Continuous Blood Glucose Monitoring Revenue by Manufacturers (2017-2020)
3.2.2 Continuous Blood Glucose Monitoring Revenue Share by Manufacturers (2017-2020)
3.3 Continuous Blood Glucose Monitoring Price by Manufacturers
3.4 Continuous Blood Glucose Monitoring Manufacturing Base Distribution, Product Types
3.4.1 Continuous Blood Glucose Monitoring Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Continuous Blood Glucose Monitoring Product Type
3.4.3 Date of International Manufacturers Enter into Continuous Blood Glucose Monitoring Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Continuous Blood Glucose Monitoring Sales by Product
4.2 Global Continuous Blood Glucose Monitoring Revenue by Product
4.3 Continuous Blood Glucose Monitoring Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Continuous Blood Glucose Monitoring Breakdown Data by End User
6 North America
6.1 North America Continuous Blood Glucose Monitoring by Countries
6.1.1 North America Continuous Blood Glucose Monitoring Sales by Countries
6.1.2 North America Continuous Blood Glucose Monitoring Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Continuous Blood Glucose Monitoring by Product
6.3 North America Continuous Blood Glucose Monitoring by End User
7 Europe
7.1 Europe Continuous Blood Glucose Monitoring by Countries
7.1.1 Europe Continuous Blood Glucose Monitoring Sales by Countries
7.1.2 Europe Continuous Blood Glucose Monitoring Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Continuous Blood Glucose Monitoring by Product
7.3 Europe Continuous Blood Glucose Monitoring by End User
8 Asia Pacific
8.1 Asia Pacific Continuous Blood Glucose Monitoring by Countries
8.1.1 Asia Pacific Continuous Blood Glucose Monitoring Sales by Countries
8.1.2 Asia Pacific Continuous Blood Glucose Monitoring Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Continuous Blood Glucose Monitoring by Product
8.3 Asia Pacific Continuous Blood Glucose Monitoring by End User
9 Central & South America
9.1 Central & South America Continuous Blood Glucose Monitoring by Countries
9.1.1 Central & South America Continuous Blood Glucose Monitoring Sales by Countries
9.1.2 Central & South America Continuous Blood Glucose Monitoring Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Continuous Blood Glucose Monitoring by Product
9.3 Central & South America Continuous Blood Glucose Monitoring by End User
10 Middle East and Africa
10.1 Middle East and Africa Continuous Blood Glucose Monitoring by Countries
10.1.1 Middle East and Africa Continuous Blood Glucose Monitoring Sales by Countries
10.1.2 Middle East and Africa Continuous Blood Glucose Monitoring Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Continuous Blood Glucose Monitoring by Product
10.3 Middle East and Africa Continuous Blood Glucose Monitoring by End User
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Business Overview
11.1.3 Roche Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Roche Continuous Blood Glucose Monitoring Products Offered
11.1.5 Roche Recent Development
11.2 Lifescan
11.2.1 Lifescan Company Details
11.2.2 Company Business Overview
11.2.3 Lifescan Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Lifescan Continuous Blood Glucose Monitoring Products Offered
11.2.5 Lifescan Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Company Business Overview
11.3.3 Medtronic Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Medtronic Continuous Blood Glucose Monitoring Products Offered
11.3.5 Medtronic Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Company Business Overview
11.4.3 Bayer AG Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Bayer AG Continuous Blood Glucose Monitoring Products Offered
11.4.5 Bayer AG Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Company Business Overview
11.5.3 Abbott Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Abbott Continuous Blood Glucose Monitoring Products Offered
11.5.5 Abbott Recent Development
11.6 Terumo
11.6.1 Terumo Company Details
11.6.2 Company Business Overview
11.6.3 Terumo Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Terumo Continuous Blood Glucose Monitoring Products Offered
11.6.5 Terumo Recent Development
11.7 Dexcom
11.7.1 Dexcom Company Details
11.7.2 Company Business Overview
11.7.3 Dexcom Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Dexcom Continuous Blood Glucose Monitoring Products Offered
11.7.5 Dexcom Recent Development
11.8 Echo Therapeutics
11.8.1 Echo Therapeutics Company Details
11.8.2 Company Business Overview
11.8.3 Echo Therapeutics Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Echo Therapeutics Continuous Blood Glucose Monitoring Products Offered
11.8.5 Echo Therapeutics Recent Development
11.9 B. Braun Melsungen
11.9.1 B. Braun Melsungen Company Details
11.9.2 Company Business Overview
11.9.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.9.4 B. Braun Melsungen Continuous Blood Glucose Monitoring Products Offered
11.9.5 B. Braun Melsungen Recent Development
11.10 Arkray
11.10.1 Arkray Company Details
11.10.2 Company Business Overview
11.10.3 Arkray Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Arkray Continuous Blood Glucose Monitoring Products Offered
11.10.5 Arkray Recent Development
11.11 Cellnovo Group
11.12 Nemaura
11.13 Tandem Diabetes Care
12 Future Forecast
12.1 Continuous Blood Glucose Monitoring Market Forecast by Regions
12.1.1 Global Continuous Blood Glucose Monitoring Sales Forecast by Regions 2019-2025
12.1.2 Global Continuous Blood Glucose Monitoring Revenue Forecast by Regions 2019-2025
12.2 Continuous Blood Glucose Monitoring Market Forecast by Product
12.2.1 Global Continuous Blood Glucose Monitoring Sales Forecast by Product 2019-2025
12.2.2 Global Continuous Blood Glucose Monitoring Revenue Forecast by Product 2019-2025
12.3 Continuous Blood Glucose Monitoring Market Forecast by End User
12.4 North America Continuous Blood Glucose Monitoring Forecast
12.5 Europe Continuous Blood Glucose Monitoring Forecast
12.6 Asia Pacific Continuous Blood Glucose Monitoring Forecast
12.7 Central & South America Continuous Blood Glucose Monitoring Forecast
12.8 Middle East and Africa Continuous Blood Glucose Monitoring Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Continuous Blood Glucose Monitoring Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
